Hemogenyx Pharmaceuticals plc announces the submission of a complete response tothe previously announced Clinical Hold of the Investigational New Drug application to the US Food and Drug Administration for HEMO-CAR-T.
Hemogenyx Pharmaceuticals plc announces the submission of a complete response tothe previously announced Clinical Hold of the Investigational New Drug application to the US Food and Drug Administration for HEMO-CAR-T.